Quote | IO Biotech Inc. (NASDAQ:IOBT)
Last: | $1.32 |
---|---|
Change Percent: | -3.01% |
Open: | $1.37 |
Close: | $1.32 |
High: | $1.37 |
Low: | $1.2788 |
Volume: | 80,823 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | IO Biotech Inc. (NASDAQ:IOBT)
2024-07-04 10:01:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the critical components of the investing world is the proliferation and understanding of analyst predictions. That’s because most retail investors prefer to research consumer info...
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, announced today that Mai-Britt Zocca, Ph.D., the company’s President and ...
Message Board Posts | IO Biotech Inc. (NASDAQ:IOBT)
Subject | By | Source | When |
---|---|---|---|
Good read | Work Harder | investorshub | 06/04/2023 4:16:10 PM |
good read | conix | investorshub | 06/04/2023 9:59:56 AM |
$IOBT Lets go go go go... Up up and away we go. | Phosphene | investorshub | 05/28/2023 8:00:56 AM |
$IOBT short squeeze | Phosphene | investorshub | 05/15/2023 8:37:05 AM |
IO Biotechs (NASDAQ:$IOBT ) lock-up period is set | Phosphene | investorshub | 05/03/2022 1:20:12 AM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, announced today that Mai-Britt Zocca, Ph.D., the company’s President and ...